Posted on 6/1/2017
The LIFE registry demonstrated safe and effective patient outcomes when using a “Fast-Track” endovascular aortic repair (EVAR) protocol—percutaneous access, no general anaesthesia, no intensive care unit admission and next-day discharge—according to data presented at the Vascular Interventional Advances (VIVA) annual conference 2016 (18–22 September, Las Vegas, USA).
Presenting the data in a late-breaking trial session, Zvonimir Krajcer, Texas Heart Institute, Houston, USA, reported no device-related or procedure-related major adverse events and 100% freedom from rupture, conversion or secondary interventions. Furthermore, Krajcer said, the Fast-Track protocol “offers significant perioperative cost savings compared to standard EVAR,”...